1 – 9 of 9
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
(
- Contribution to journal › Article
-
Mark
The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
(
- Contribution to journal › Article
- 2016
-
Mark
Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
(
- Contribution to journal › Article
- 2015
-
Mark
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease.
(
- Contribution to journal › Article
-
Mark
A score to predict short-term risk of COPD exacerbations (SCOPEX).
(
- Contribution to journal › Article
-
Mark
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
(
- Contribution to journal › Article
- 2013
-
Mark
Factor analysis in predominantly severe COPD: Identification of disease heterogeneity by easily measurable characteristics
(
- Contribution to journal › Article
- 2011
-
Mark
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
(
- Contribution to journal › Article
- 2010
-
Mark
Overall asthma control: The relationship between current control and future risk
(
- Contribution to journal › Article